Publications:

Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.

Antimicrobial Agents And Chemotherapy

Cabot, Gabriel G; Bruchmann, Sebastian S; Mulet, Xavier X; Zamorano, Laura L; Moyà, Bartolomé B; Juan, Carlos C; Haussler, Susanne S; Oliver, Antonio A

Publication Date: 2014-06

Variant appearance in text: ATM: I279T

PubMed Link: 24637685

Variant Present in the following documents:

• Main text

View BVdb publication page